Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/138981
Title: An ImmunoPEGliposome for Targeted Antimalarial Combination Therapy at the Nanoscale
Author: Biosca, Arnau
Dirscherl, Lorin
Moles Meler, Ernest
Imperial Ródenas, Santiago
Fernàndez Busquets, Xavier
Keywords: Malària
Nanomedicina
Malaria
Nanomedicine
Issue Date: 16-Jul-2019
Publisher: MDPI
Abstract: Combination therapies, where two drugs acting through different mechanisms are administered simultaneously, are one of the most efficient approaches currently used to treat malaria infections. However, the different pharmacokinetic profiles often exhibited by the combined drugs tend to decrease treatment efficacy as the compounds are usually eliminated from the circulation at different rates. To circumvent this obstacle, we have engineered an immunoliposomal nanovector encapsulating hydrophilic and lipophilic compounds in its lumen and lipid bilayer, respectively. The antimalarial domiphen bromide has been encapsulated in the liposome membrane with good efficiency, although its high IC50 of ca. 1 µM for living parasites complicates its use as immunoliposomal therapy due to erythrocyte agglutination. The conjugation of antibodies against glycophorin A targeted the nanocarriers to Plasmodium-infected red blood cells and to gametocytes, the sole malaria parasite stage responsible for the transmission from the human to the mosquito vector. The antimalarials pyronaridine and atovaquone, which block the development of gametocytes, have been co-encapsulated in glycophorin A-targeted immunoliposomes. The co-immunoliposomized drugs have activities significantly higher than their free forms when tested in in vitro Plasmodium falciparum cultures: Pyronaridine and atovaquone concentrations that, when encapsulated in immunoliposomes, resulted in a 50% inhibition of parasite growth had no effect on the viability of the pathogen when used as free drugs.
Note: Reproducció del document publicat a: http://dx.doi.org/10.3390/pharmaceutics11070341
It is part of: Pharmaceutics, 2019, vol. 11, num. 7
URI: http://hdl.handle.net/2445/138981
Related resource: http://dx.doi.org/10.3390/pharmaceutics11070341
ISSN: 1999-4923
Appears in Collections:Articles publicats en revistes (ISGlobal)
Articles publicats en revistes (Institut de Nanociència i Nanotecnologia (IN2UB))
Articles publicats en revistes (Bioquímica i Biomedicina Molecular)
Articles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))

Files in This Item:
File Description SizeFormat 
BioscaA_Pharmaceutics_2019.pdf18.59 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons